MedTrace Logo

Dexamethasone for Postoperative Nausea and Vomiting

NCT00825071 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-05-13

No results posted yet for this study

Summary

The investigators want to test the efficacy of these anesthetic antiemetic measures collectively with or without ondansetron or dexamethasone, in the prevention of postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

Dexamethasone

8 mg, Intravenous

DRUG

Ondansetron

4 mg, intravenously

DRUG

normal saline

2 ml, intravenously

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Subhi M Al-Ghanem, MD, FFARCSI · University of Jordan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00825071 on ClinicalTrials.gov